Revista de ingeniería bioquímica y tecnología de bioprocesos

Monoclonal Antibody- Drug Conjugation

Kiran Kumar M*

Developing drugs that are ready to target disease and spare healthy tissue has beena long?time goal of both oncologic and non?oncologic drug development. Sincethe late nineteenth century, it's been recognized that effective treatment of disease by therapeutic agents is improved when therapeutics demonstrate selectiveness for foreign bodies (bacteria) or diseased cells and spare healthy cells.